Page last updated: 2024-08-25

clarithromycin and clofazimine

clarithromycin has been researched along with clofazimine in 70 studies

Research

Studies (70)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's23 (32.86)18.2507
2000's24 (34.29)29.6817
2010's19 (27.14)24.3611
2020's4 (5.71)2.80

Authors

AuthorsStudies
Casciano, CN; Clement, RP; Johnson, WW; Wang, EJ1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Cynamon, MH; DeStefano, MS; Klemens, SP1
Cynamon, MH; Klemens, SP; Swenson, CE1
De Gregoris, P; Fattorini, L; Hu, CQ; Iona, E; Mascellino, MT; Orefici, G; Santoro, C1
Michałowska-Mitczuk, D1
Dekio, S; Hidaka, T; Kawahara, S; Saito, H; Sato, K; Tomioka, H1
Chauvin, JP; Dautzenberg, B; Durant, J; Legrand, MF; Meyohas, MC; Reynes, J; Saint-Marc, T; Truffot, C1
Marneff, E; Saint-Marc, T; Touraine, JL1
Fanning, MM; Fong, IW; Gill, MJ; Lalonde, RG; Phillips, P; Rachlis, AR; Salit, I; Shafran, SD; Singer, J; Tsoukas, CM; Walmsley, SL; Zarowny, DP1
Coker, RJ; Fisher, M; Tomlinson, DR1
Benson, CA; Chaisson, RE; Craft, JC; Fessel, WJ; Keiser, P; Lahart, C; Meek, K; Pierce, M; Ruskin, J; Siepman, N1
Beuscart, C; Brel, F; Dautzenberg, B; Doco-Lecompte, T; Grosset, J; May, T; Perronne, C; Saint-Marc, T; Vincent, V1
Igual, J; Roussel, G1
Horgen, L; Legrand, E; Rastogi, N1
Horgen, L; Jerome, A; Rastogi, N1
Dubé, MP; Havlir, DV; Kemper, CA; Leedom, JM; McCutchan, JA; Sattler, FR; See, D; Tilles, JG; Torriani, FJ1
Burguière, AM; Eliaszewicz, M; Flahault, A; Fournier, S; Treilhou, MP; Vincent, V1
Chesnut, J; Child, CC; Clotfelter, J; Cohn, DL; El-Sadr, W; Fisher, EJ; Franchino, B; Gibert, CL; Hafner, R; Heifets, L; Hodges, JS; Horsburgh, CR; Korvick, J; Munroe, D; Peng, GT; Ropka, M1
Khorasheh, S; Lemieux, C; Raboud, JM; Salit, I; Shafran, SD; Singer, J; Thorne, A; Tsoukas, CM; Wu, AW1
Chen, SC; Furber, H; Hughes, MS; James, G; Love, DN; Lucas, A; Lucas, J; Malik, R; Martin, P; Mitchell, DH1
Kashiwabara, Y; Matsuoka, M; Namisato, M1
Cheng, B1
Prescott, LM1
Currier, J1
Hermon-Taylor, J2
Canfield, PJ; Chen, SC; Hughes, MS; James, G; Love, DN; Malik, R; Martin, P; Mitchell, DH; Wigney, DI1
Borody, TJ; Leis, S; Surace, R; Warren, EF1
Duangdeeden, I; Kullavanijaya, P; Rattana-Apiromyakij, N; Sirimachand, S; Sukonthapirom-Napattalung, P1
Chimara, E; da Silva Telles, MA; Ferrazoli, L; Riley, LW1
Gidoh, M; Matsuoka, M; Yamazaki, T1
Greene, CE; Latimer, KS; Sanchez, S; Sessions, JK; Sieber-Ruckstuhl, NS1
Bilkey, S; Borody, TJ; Leis, S; Pang, G; Tye, S; Wettstein, AR1
Connell, W; Crotty, B; Ee, H; Florin, T; Gibson, P; Hetzel, D; Merrett, M; Mitchell, B; Pavli, P; Radford-Smith, G; Read, R; Selby, W1
Colombel, JF; Neut, C; Peyrin-Biroulet, L1
Kuenstner, JT1
Barash, DP; Lipton, JE1
Biesecker, J; Gitlin, L1
Chamberlin, W1
Behr, MA; Hanley, J1
Agnihotri, SP; Gupta, P; Gupta, S; Jain, NK; Sharma, KK1
Alffenaar, JW; Bolhuis, MS; Kosterink, JG; Uges, DR; van Altena, R; van der Werf, TS1
Fu, L; Li, P; Liang, BW; Lu, Y; Wang, B; Zhao, WJ; Zheng, MQ1
Hassan, G; Kant, S; Parengal, J; Saheer, S1
Uthman, MM; Uthman, OA; Yahaya, I1
Adamson, J; Converse, PJ; Grosset, JH; Kishi, Y; Li, SY; Nuermberger, EL; Tyagi, S; Xing, Y1
Andries, K; Arnett, KA; Creissen, E; Henao-Tamayo, M; Lenaerts, AJ; Massoudi, L; Obregón-Henao, A; Ordway, DJ1
de Jong, A; Ferro, BE; Meletiadis, J; Mouton, JW; van Ingen, J; van Soolingen, D; Wattenberg, M1
Achar, J; Bobokhojaev, OI; du Cros, P; Dusmatova, Z; Quinnell, S; Seddon, JA; Swaminathan, A1
Chande, N; MacDonald, JK; Parker, CE; Patton, PH1
Brouqui, P; Drancourt, M; Quenard, F1
Chen, HC; Huang, CC; Huang, WC; Wu, MF1
Jo, KW; Nam, GB; Shim, TS; Yoon, HY1
Zheng, S1
Ishii, N; Richardson, M; Yotsu, RR1
Bertani, L; Blandizzi, C; Bodini, G; Buda, A; Ceccarelli, L; Costa, F; De Bortoli, N; Facchin, S; Lorenzon, G; Marabotto, E; Marchi, S; Savarino, E; Savarino, V; Zingone, F1
Almeida, DV; Converse, PJ; Nuermberger, EL; Tyagi, S; Xu, J1
Jevert-Eichorn, S; Radigan, A1
Chen, J; Chen, X; Hua, W; Lin, S; Liu, H; Shao, L; Wang, S; Zhang, W; Zhang, Y1
Almond, LM; Beringer, PM; Chung, PS; Hong, E; Rao, AP1
Ammerman, NC; Bax, HI; de Steenwinkel, JEM; de Vogel, CP; Mudde, SE; Schildkraut, JA; van Ingen, J1
Çavuşoğlu, C; Gazi, H; Özkütük, N; Sürücüoğlu, S1

Reviews

7 review(s) available for clarithromycin and clofazimine

ArticleYear
[Patients with chronic sputum positive tuberculosis-a therapeutic problem].
    Pneumonologia i alergologia polska, 1995, Volume: 63, Issue:1-2

    Topics: Amikacin; Amoxicillin; Antitubercular Agents; Chronic Disease; Clarithromycin; Clofazimine; Humans; Rifabutin; Sputum; Tuberculosis, Pulmonary

1995
Antimycobacterial therapy in Crohn's disease: game over?
    Gastroenterology, 2007, Volume: 132, Issue:7

    Topics: Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Drug Therapy, Combination; Humans; Mycobacterium avium; Mycobacterium Infections; Rifabutin

2007
Interventions for the prevention of mycobacterium avium complex in adults and children with HIV.
    The Cochrane database of systematic reviews, 2013, Apr-30, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Child; Clarithromycin; Clofazimine; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Randomized Controlled Trials as Topic; Rifabutin

2013
Anti-tuberculous therapy for maintenance of remission in Crohn's disease.
    The Cochrane database of systematic reviews, 2016, Jul-22, Volume: 7

    Topics: Antitubercular Agents; Clarithromycin; Clofazimine; Crohn Disease; Ethambutol; Glucocorticoids; Humans; Maintenance Chemotherapy; Methylprednisolone; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Rifabutin; Rifampin; Secondary Prevention

2016
Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB).
    International journal of antimicrobial agents, 2017, Volume: 49, Issue:5

    Topics: Antitubercular Agents; Clarithromycin; Clofazimine; Drug Resistance, Multiple, Bacterial; Drug Synergism; Extensively Drug-Resistant Tuberculosis; Humans; Minocycline; Mycobacterium tuberculosis; Phenothiazines; Sulfonamides

2017
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).
    The Cochrane database of systematic reviews, 2018, 08-23, Volume: 8

    Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Clofazimine; Drug Therapy, Combination; Humans; Mycobacterium ulcerans; Observational Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination

2018
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn's disease: pharmacological and clinical implications.
    Expert opinion on biological therapy, 2019, Volume: 19, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Drug Combinations; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Remission Induction; Rifabutin

2019

Trials

13 trial(s) available for clarithromycin and clofazimine

ArticleYear
New antibiotics look good against M. avium.
    The American journal of nursing, 1992, Volume: 92, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Azithromycin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Erythromycin; Humans; Mycobacterium avium-intracellulare Infection

1992
[Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection].
    Revue des maladies respiratoires, 1994, Volume: 11, Issue:3

    Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Child; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fluoroquinolones; Hearing Disorders; Humans; Liver Function Tests; Male; Middle Aged; Minocycline; Mycobacterium avium-intracellulare Infection; Recurrence; Treatment Outcome

1994
[Mycobacterium avium intracellulare infections. Treatment with a clarithromycin-clofazimine combination. 18 cases].
    Presse medicale (Paris, France : 1983), 1993, Dec-04, Volume: 22, Issue:38

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Chemical and Drug Induced Liver Injury; Clarithromycin; Clofazimine; Drug Therapy, Combination; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection

1993
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    The New England journal of medicine, 1996, Aug-08, Volume: 335, Issue:6

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Survival Analysis; Treatment Outcome; Uveitis

1996
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
    AIDS (London, England), 1997, Volume: 11, Issue:3

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium-intracellulare Infection

1997
Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le Sida.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25, Issue:3

    Topics: Adult; AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Prospective Studies; Recurrence; Rifabutin

1997
Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome. GETIM. Groupe d'Etude et de Traitement des Infections à Mycobactéries.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1998, Volume: 2, Issue:6

    Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Seronegativity; Humans; Male; Middle Aged; Minocycline; Mycobacterium avium-intracellulare Infection; Treatment Outcome; Tuberculosis, Pulmonary

1998
Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 28, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin

1999
Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999, Volume: 18, Issue:1

    Topics: Aged; AIDS-Related Opportunistic Infections; Anti-Inflammatory Agents, Non-Steroidal; Bacteremia; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Survival Analysis

1999
A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Resear
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 29, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Clofazimine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Patient Compliance; Prospective Studies; Rifabutin; Survivors; Treatment Outcome

1999
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group.
    International journal of STD & AIDS, 2000, Volume: 11, Issue:4

    Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Bacteremia; Canada; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Health Status; Humans; Mycobacterium avium-intracellulare Infection; Outcome and Process Assessment, Health Care; Rifabutin; Rifampin; Treatment Outcome

2000
Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2007, Volume: 39, Issue:5

    Topics: Adolescent; Adult; Anti-Infective Agents; Clarithromycin; Clofazimine; Crohn Disease; Female; Humans; Intestinal Mucosa; Male; Middle Aged; Mycobacterium avium; Retrospective Studies; Rifabutin; Treatment Outcome

2007
Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Gastroenterology, 2007, Volume: 132, Issue:7

    Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Middle Aged; Mycobacterium avium; Mycobacterium Infections; Patient Compliance; Prednisolone; Rifabutin; Treatment Failure

2007

Other Studies

50 other study(ies) available for clarithromycin and clofazimine

ArticleYear
Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.
    Biochemical and biophysical research communications, 2001, Nov-30, Volume: 289, Issue:2

    Topics: 3T3 Cells; Adrenergic Uptake Inhibitors; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport, Active; Cell Line; Cell Separation; Cell Survival; Flow Cytometry; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Mice; Protein Binding; Reserpine; Spectrometry, Fluorescence; Substrate Specificity; Time Factors

2001
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:11

    Topics: Amikacin; Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred C57BL; Mycobacterium avium; Mycobacterium avium Complex; Quinolones; Rifabutin; Rifampin; Rifamycins; Time Factors; Tuberculosis

1992
TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 29, Issue:6

    Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Culture Media; Drug Therapy, Combination; Erythromycin; Ethambutol; Gentamicins; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Tuberculosis

1992
In vitro activity of clarithromycin alone or in combination with other antimicrobial agents against Mycobacterium avium-intracellulare. Complex strains isolated from AIDS patients.
    Journal of chemotherapy (Florence, Italy), 1991, Volume: 3, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Synergism; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Radiometry

1991
Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice.
    Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1995, Volume: 76, Issue:1

    Topics: Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Drug Synergism; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolones; Rifamycins; Streptomycin

1995
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
    International journal of STD & AIDS, 1996, Volume: 7, Issue:4

    Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

1996
Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium.
    Research in microbiology, 1997, Volume: 148, Issue:8

    Topics: Amikacin; Anti-Bacterial Agents; Bacteriological Techniques; Clarithromycin; Clofazimine; Colony Count, Microbial; Fluoroquinolones; Humans; Mycobacterium avium Complex; Quinolones; Rifampin; Serum Bactericidal Test

1997
Pulsed-exposure and postantibiotic leukocyte enhancement effects of amikacin, clarithromycin, clofazimine, and rifampin against intracellular Mycobacterium avium.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:11

    Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Humans; Leukocytes; Macrophages; Mycobacterium avium; Phagocytosis; Rifampin

1998
Mycobacterium genavense infection in two aged ferrets with conjunctival lesions.
    Australian veterinary journal, 2000, Volume: 78, Issue:10

    Topics: Animals; Clarithromycin; Clofazimine; Conjunctivitis, Bacterial; Diagnosis, Differential; DNA Primers; Drug Therapy, Combination; Fatal Outcome; Female; Ferrets; Male; Mycobacterium; Mycobacterium Infections; Polymerase Chain Reaction; Rifampin; RNA, Bacterial

2000
A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 2000, Volume: 68, Issue:4

    Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Colony Count, Microbial; Dapsone; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Leprostatic Agents; Leprosy; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mycobacterium leprae; Ofloxacin; Rifampin

2000
Advances in prevention and treatment of MAC.
    PI perspective, 1995, Issue:no 17

    Topics: AIDS-Related Opportunistic Infections; Azithromycin; CD4 Lymphocyte Count; Clarithromycin; Clinical Trials as Topic; Clofazimine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin

1995
Macrolides, azalides, and streptogrammins.
    Journal of the International Association of Physicians in AIDS Care, 1996, Volume: 2, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteremia; Bacterial Infections; Clarithromycin; Clofazimine; Cryptosporidiosis; Drug Therapy, Combination; Duodenal Ulcer; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Pneumonia; Smoking; Virginiamycin

1996
Progress report: prophylaxis and therapy for MAC.
    AIDS clinical care, 1996, Volume: 8, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; Azithromycin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin

1996
Pot shots.
    Notes from the underground (New York, N.Y.), 1996, Issue:No 33

    Topics: Acetylcysteine; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Antitubercular Agents; Antiviral Agents; Cattle; CD4 Lymphocyte Count; China; Clarithromycin; Clinical Trials as Topic; Clofazimine; Cryptosporidiosis; Drug Combinations; Ethambutol; Expectorants; Glutathione; Hepatitis B; Humans; Immunoglobulins; Interferon-alpha; Italy; Leprostatic Agents; Mycobacterium avium-intracellulare Infection; Philippines; Protease Inhibitors; Survival Rate; Taiwan; Thymosin; Zidovudine

1996
MAC management.
    PI perspective, 1996, Issue:No 20

    Topics: Acquired Immunodeficiency Syndrome; Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Interactions; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Tuberculin Test; Zidovudine

1996
Protagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease.
    Gut, 2001, Volume: 49, Issue:6

    Topics: Animals; Animals, Domestic; Cattle; Clarithromycin; Clofazimine; Crohn Disease; Disease Reservoirs; Drug Therapy, Combination; Humans; Intestines; Milk; Mycobacterium avium subsp. paratuberculosis; Rifabutin; Sheep

2001
Feline leprosy: two different clinical syndromes.
    Journal of feline medicine and surgery, 2002, Volume: 4, Issue:1

    Topics: Animals; Cat Diseases; Cats; Clarithromycin; Clofazimine; Female; Leprostatic Agents; Leprosy, Lepromatous; Male; Mycobacterium; Polymerase Chain Reaction; Rifampin; RNA, Ribosomal, 16S

2002
Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2002, Volume: 34, Issue:1

    Topics: Adolescent; Adult; Clarithromycin; Clofazimine; Colonoscopy; Crohn Disease; Drug Therapy, Combination; Female; Humans; Male; Mycobacterium avium subsp. paratuberculosis; Mycobacterium Infections; Pilot Projects; Prospective Studies; Rifabutin; Severity of Illness Index; Treatment Outcome

2002
Treatment with drugs active against Mycobacterium avium subspecies paratuberculosis can heal Crohn's disease: more evidence for a neglected public health tragedy.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2002, Volume: 34, Issue:1

    Topics: Clarithromycin; Clofazimine; Crohn Disease; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Rifabutin; Vaccines, DNA

2002
Disseminated Mycobacterium chelonae cutaneous infection: recalcitrant to combined antibiotic therapy.
    The Journal of dermatology, 2003, Volume: 30, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Cryotherapy; Drug Resistance; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial

2003
Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
    Journal of medical microbiology, 2005, Volume: 54, Issue:Pt 10

    Topics: Amikacin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Clarithromycin; Clofazimine; Cycloserine; DNA Fingerprinting; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifabutin; Rifampin; Streptomycin

2005
[Basic evaluation for new antimicrobial susceptibility testing of Mycobacterium leprae by bioluminescence assay (ATP method)].
    Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association, 2006, Volume: 75, Issue:3

    Topics: Animals; Clarithromycin; Clofazimine; Drug Resistance, Bacterial; Leprostatic Agents; Leprosy; Luciferases; Luminescent Agents; Mice; Mice, Nude; Microbial Sensitivity Tests; Mycobacterium leprae; Ofloxacin; Rifampin

2006
Long-term cure of disseminated Mycobacterium avium infection in a cat.
    The Veterinary record, 2007, Jan-27, Volume: 160, Issue:4

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clarithromycin; Clofazimine; Diagnosis, Differential; Doxycycline; Male; Mycobacterium avium; Tuberculosis

2007
The Australian antibiotic trial in Crohn's disease: alternative conclusions from the same study.
    Gastroenterology, 2007, Volume: 133, Issue:5

    Topics: Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Drug Therapy, Combination; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Rifabutin

2007
Flawed Australian CD study does not end MAP controversy.
    Gastroenterology, 2007, Volume: 133, Issue:5

    Topics: Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Drug Therapy, Combination; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Randomized Controlled Trials as Topic; Rifabutin

2007
Australian Crohn's antibiotic study opens new horizons.
    Gastroenterology, 2007, Volume: 133, Issue:5

    Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Clarithromycin; Clofazimine; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Infliximab; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Randomized Controlled Trials as Topic; Remission Induction; Reproducibility of Results; Rifabutin; Treatment Outcome

2007
Importance of the Australian Crohn's disease antibiotic study.
    Gastroenterology, 2007, Volume: 133, Issue:5

    Topics: Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Data Interpretation, Statistical; Drug Therapy, Combination; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Randomized Controlled Trials as Topic; Rifabutin; Treatment Outcome

2007
Antimycobacterial therapy for Crohn's disease: a reanalysis.
    The Lancet. Infectious diseases, 2008, Volume: 8, Issue:6

    Topics: Adrenal Cortex Hormones; Antitubercular Agents; Clarithromycin; Clinical Trials as Topic; Clofazimine; Crohn Disease; Humans; Rifabutin

2008
Extensively drug resistance (XDR) tb is not always fatal.
    The Indian journal of tuberculosis, 2009, Volume: 56, Issue:1

    Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Aza Compounds; Capreomycin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; India; Injections; Male; Moxifloxacin; Quinolines; Sputum; Treatment Outcome

2009
Clarithromycin significantly increases linezolid serum concentrations.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Acetamides; Adult; Chromatography, Liquid; Clarithromycin; Clofazimine; Cycloserine; Drug Interactions; Humans; Linezolid; Male; Oxazolidinones; Tandem Mass Spectrometry; Tuberculosis, Pulmonary

2010
[A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2010, Volume: 33, Issue:9

    Topics: Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2010
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
    BMJ case reports, 2012, May-08, Volume: 2012

    Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant

2012
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease.
    PLoS neglected tropical diseases, 2015, Volume: 9, Issue:6

    Topics: Animals; Buruli Ulcer; Clarithromycin; Clofazimine; Colony Count, Microbial; Drug Evaluation, Preclinical; Drug Therapy, Combination; Foot; Macrolides; Mice; Microbial Sensitivity Tests; Rifampin; Streptomycin; Survival Analysis; Time Factors; Treatment Outcome

2015
Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Diarylquinolines; Granulocyte-Macrophage Colony-Stimulating Factor; Mice; Mice, Knockout; Mice, SCID; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections

2015
Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Monte Carlo Method; Mutation; Mycobacterium avium; Nontuberculous Mycobacteria

2016
Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, Volume: 20, Issue:4

    Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Child; Child, Preschool; Clarithromycin; Clofazimine; Drug Combinations; Extensively Drug-Resistant Tuberculosis; Female; Follow-Up Studies; Humans; Linezolid; Male; Retrospective Studies; Sputum; Tajikistan; Treatment Outcome

2016
In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Cycloserine; Drug Synergism; Fluoroquinolones; Gentamicins; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Sputum; Streptomycin

2018
Clinical significance of QT-prolonging drug use in patients with MDR-TB or NTM disease.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2017, 09-01, Volume: 21, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Azithromycin; Child; Clarithromycin; Clofazimine; Diarylquinolines; Female; Fluoroquinolones; Follow-Up Studies; Humans; Lost to Follow-Up; Macrolides; Male; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nitroimidazoles; Nontuberculous Mycobacteria; Oxazoles; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult

2017
Nodular skin lesion secondary to Mycobacterium abscessus tenosynovitis.
    QJM : monthly journal of the Association of Physicians, 2018, Dec-01, Volume: 111, Issue:12

    Topics: Aged; Clarithromycin; Clofazimine; Debridement; Female; Fingers; Humans; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Skin Diseases; Tenosynovitis

2018
Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Buruli Ulcer; Clarithromycin; Clofazimine; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Electron Transport; Humans; Imidazoles; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium ulcerans; Piperidines; Pyridines; Rifampin; Streptomycin

2019
Rare case of pacemaker infection with
    BMJ case reports, 2019, Sep-17, Volume: 12, Issue:9

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Arrhythmias, Cardiac; Cefoxitin; Clarithromycin; Clofazimine; Drug Resistance, Bacterial; Epidural Abscess; Heroin Dependence; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Osteomyelitis; Pacemaker, Artificial; Prosthesis-Related Infections

2019
In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates.
    BMC microbiology, 2022, 07-08, Volume: 22, Issue:1

    Topics: Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Clofazimine; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin

2022
Physiologically Based Pharmacokinetic Modeling To Guide Management of Drug Interactions between Elexacaftor-Tezacaftor-Ivacaftor and Antibiotics for the Treatment of Nontuberculous Mycobacteria.
    Antimicrobial agents and chemotherapy, 2022, 11-15, Volume: 66, Issue:11

    Topics: Anti-Bacterial Agents; Benzodioxoles; Clarithromycin; Clofazimine; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Nontuberculous Mycobacteria; Pyrrolidines; Rifabutin

2022
Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps.
    Journal of global antimicrobial resistance, 2022, Volume: 31

    Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Clofazimine; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Thioridazine; Tigecycline; Verapamil

2022
[In vitro Activity of Rifabutin and Clofazimine to Macrolide-Resistant Mycobacterium abscessus Complex Clinical Isolates].
    Mikrobiyoloji bulteni, 2023, Volume: 57, Issue:4

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Drug Resistance, Bacterial; Humans; Macrolides; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Rifabutin

2023